Evidence map›Paper›PMID 37860589›Full record

ArticleThe mental health clinician2023

Comment on "Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review".

Mark S Todtenkopf, Christoph U Correll, Marni E Harris-White, Michael J Doane, David McDonnell

Abstract read
In one paragraph

Article in The mental health clinician, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mark S TodtenkopfDirector, Scientific Communications, Alkermes Inc, Waltham, Massachusetts.ORCID https://orcid.org/0000-0003-4764-7816
Christoph U CorrellProfessor of Psychiatry, The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York; Professor of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, New York; Professor of Child and Adolescent Psychiatry and Department Chair, Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.ORCID https://orcid.org/0000-0002-7254-5646
Marni E Harris-WhiteMedical Director, Medical Affairs Strategy, Alkermes Inc, Waltham, Massachusetts.ORCID https://orcid.org/0000-0001-8994-3715
Michael J DoaneDirector, Health Economics & Outcomes Research, Alkermes Inc, Waltham, Massachusetts.ORCID https://orcid.org/0009-0006-6102-2459
David McDonnellDirector, Scientific Communications, Alkermes Inc, Waltham, Massachusetts.ORCID https://orcid.org/0000-0002-6400-1286

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37860589
PMCPMC10583260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.